New CEO at Carl Zeiss Meditec
Dr Ludwin Monz is now the new CEO of Carl Zeiss Meditec, having taken over from Dr Michael Kaschke. Kaschke has been elected back to the Supervisory Board and was appointed its Chairman in a subsequent Supervisory Board meeting.
Dr Ludwin Monz is now the new CEO of Carl Zeiss Meditec, having taken over from Dr. Michael Kaschke. Kaschke has been elected back to the Supervisory Board and was appointed its Chairman in a subsequent Supervisory Board meeting.
I am looking forward to the new task and will continue the path the company has taken towards sustainable growth, explains Dr Ludwin Monz, CEO of Carl Zeiss Meditec AG. Customer-oriented innovation, excellent service and expansion into new markets as part of our corporate RACE programme are clearly the three most important strategic initiatives for the coming months.
Dr Monz has been a member of Carl Zeiss Meditec AG's Management Board since October 2007 and is responsible for the largest strategic business unit, Ophthalmological Systems. Prior to this he headed up the Microsurgery strategic business unit for over six years. With a doctorate in physics and an MBA, Monz joined the Carl Zeiss Group in 1994 and has worked in medical technology since 2000.
